000518 *ST四环生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-3.439-10.503-25.777-14.490-8.389
总资产报酬率 ROA (%)-2.325-6.989-17.909-10.760-6.347
投入资产回报率 ROIC (%)-2.894-8.835-22.132-12.951-7.593

边际利润分析
销售毛利率 (%)19.13237.30262.68269.76171.035
营业利润率 (%)-15.408-11.767-38.747-32.517-20.047
息税前利润/营业总收入 (%)-14.881-11.389-54.869-32.725-19.249
净利润/营业总收入 (%)-15.132-11.502-55.920-34.158-19.723

收益指标分析
经营活动净收益/利润总额(%)104.99380.85033.03065.80676.611
价值变动净收益/利润总额(%)0.082-8.616-0.441-2.1750.487
营业外收支净额/利润总额(%)0.0000.97630.6653.618-1.028

偿债能力分析
流动比率 (X)3.1503.6273.3394.3114.860
速动比率 (X)1.5031.5630.6480.8541.343
资产负债率 (%)27.57327.26129.68422.42119.589
带息债务/全部投入资本 (%)10.0806.9409.5626.0375.202
股东权益/带息债务 (%)818.8411,235.395865.0561,464.9781,734.084
股东权益/负债合计 (%)244.688248.456220.694325.050385.412
利息保障倍数 (X)-28.235-23.023-54.078-32.322-32.414

营运能力分析
应收账款周转天数 (天)79.32670.359120.182129.931146.201
存货周转天数 (天)266.597482.4661,821.1282,066.5601,930.987